(Q45254374)

English

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

ductal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Laura C Collins

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Stuart J Schnitt

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

615-620

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.3800360

0 references

Ductal Carcinoma in Situ of the Breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Tamoxifen: Dr. Jekyll and Mr. Hyde?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

21 January 2018

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor immunohistochemistry in carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological profile of in situ breast cancer investigated by immunohistochemical technique

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Oestrogen receptor expression in the normal and pre-cancerous breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Duct carcinoma in situ. Pathology and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800360

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.3800360

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45254374&oldid=2103823102"